Amarin Corp. Plc (AMRN)
14.26
+0.30
(+2.15%)
USD |
NASDAQ |
Mar 03, 16:00
14.33
+0.07
(+0.49%)
After-Hours: 20:00
Amarin Research and Development Expense (Annual) : 19.85M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Trinity Biotech Plc | 4.535M |
| Alkermes Plc | 318.36M |
| Jazz Pharmaceuticals Plc | 782.74M |
| DBV Technologies SA | 89.90M |
| Cellectis SA | 72.02M |